Haloenol lactones. Potent enzyme-activated irreversible inhibitors for alpha-chymotrypsin
- PMID: 6654902
Haloenol lactones. Potent enzyme-activated irreversible inhibitors for alpha-chymotrypsin
Abstract
Haloenol lactones can act as enzyme-activated irreversible inhibitors for alpha-chymotrypsin: acyl transfer to the active site serine releases a halomethyl ketone that remains tethered in the active site during the lifetime of the acyl enzyme, poised to alkylate an accessible nucleophilic residue. To investigate the structural determinants for chymotrypsin suicide inactivation with haloenol lactones, we prepared a series of nine lactones, differing in ring size (6-membered valerolactones and 5-membered butyrolactones) and in the nature of the aromatic substituent (phenyl and alpha-naphthyl), and the halogen (bromine and iodine). The inactivating behavior of these lactones is characterized by a binding constant (Ki) and three rate constants, for inactivation (k2), catalytic hydrolysis (kc), and spontaneous hydrolysis (kh). The six-membered valerolactones were much more potent inactivators than the butyrolactones, having both higher affinity and more rapid inactivation; the alpha-naphthyl-substituted lactones were also more effective, but the nature of the halogen had relatively little effect. The spontaneous rate of hydrolysis of all of these lactones is low. The turnovers per inactivation of these lactones vary from 91-1.7, with some of the alpha-naphthyl-substituted lactones approaching ideal behavior (stoichiometric inactivation). These studies indicate that several haloenol lactones are effective enzyme-activated irreversible inhibitors of chymotrypsin, and that their potency and efficiency depends markedly upon certain structural features of the lactone system.
Similar articles
-
Halo enol lactones: studies on the mechanism of inactivation of alpha-chymotrypsin.Biochemistry. 1986 Mar 25;25(6):1436-44. doi: 10.1021/bi00354a037. Biochemistry. 1986. PMID: 3964685
-
Haloenol lactones as inactivators and substrates of aldehyde dehydrogenase.J Protein Chem. 1996 Oct;15(7):639-48. doi: 10.1007/BF01886746. J Protein Chem. 1996. PMID: 8968955
-
Haloenol lactones: enzyme-activated irreversible inactivators for serine proteases. Inactivation of alpha-chymotrypsin.J Biol Chem. 1982 Jan 25;257(2):610-2. J Biol Chem. 1982. PMID: 7054169
-
Enol lactone inhibitors of serine proteases. The effect of regiochemistry on the inactivation behavior of phenyl-substituted (halomethylene)tetra- and -dihydrofuranones and (halomethylene)tetrahydropyranones toward alpha-chymotrypsin: stable acyl enzyme intermediate.J Med Chem. 1986 Feb;29(2):230-8. doi: 10.1021/jm00152a011. J Med Chem. 1986. PMID: 3512826
-
Halo enol lactone inhibitors of chymotrypsin: burst kinetics and enantioselectivity of inactivation.Biochem Biophys Res Commun. 1991 Aug 15;178(3):1335-42. doi: 10.1016/0006-291x(91)91040-j. Biochem Biophys Res Commun. 1991. PMID: 1872851
Cited by
-
Genetic ablation of calcium-independent phospholipase A(2)γ (iPLA(2)γ) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release.J Biol Chem. 2012 Aug 24;287(35):29837-50. doi: 10.1074/jbc.M112.373654. Epub 2012 Jul 9. J Biol Chem. 2012. PMID: 22778252 Free PMC article.
-
Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.J Biol Chem. 2006 Jul 28;281(30):20958-20973. doi: 10.1074/jbc.M600075200. Epub 2006 May 27. J Biol Chem. 2006. PMID: 16732058 Free PMC article.
-
Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2beta.J Biol Chem. 2008 Dec 5;283(49):33975-87. doi: 10.1074/jbc.M805817200. Epub 2008 Oct 16. J Biol Chem. 2008. PMID: 18927078 Free PMC article.
-
Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster.BMC Pharmacol. 2004 Apr 19;4:5. doi: 10.1186/1471-2210-4-5. BMC Pharmacol. 2004. PMID: 15096274 Free PMC article.
-
Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes.PLoS One. 2013 Aug 20;8(8):e71748. doi: 10.1371/journal.pone.0071748. eCollection 2013. PLoS One. 2013. PMID: 23977134 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources